Researchers have found that the aggressive brain cancer glioblastoma can take over the formation of new synapses to fuel its own growth. This neural redirection also appears to play a role in the cognitive decline seen in many people with this cancer.
A new study finds that pancreatic cancer cells have a ready way to overcome a lack of glucose, something that happens often in this disease. They use another fuel source called uridine. Findings from a related study suggest other cancers do as well.
In a large clinical trial, the targeted drug vorasidenib slowed the growth of low-grade gliomas that had mutations in the IDH1 or IDH2 genes. Vorasidenib is the first targeted drug developed specifically to treat brain tumors.
Most cases of colorectal cancer are diagnosed after age 50, but new cases in people younger than 50 have been on the rise. Learn about risk factors and protective factors that might affect a person's risk of colorectal cancer.
Melanoma is a rare form of skin cancer that is more likely than other types of skin cancer to spread to other parts of the body. Find out about risk factors and symptoms of melanoma and how it is diagnosed and treated.
Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.
This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892
No comments:
Post a Comment